154 related articles for article (PubMed ID: 21989534)
1. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer.
Epstein AS; Soff GA; Capanu M; Crosbie C; Shah MA; Kelsen DP; Denton B; Gardos S; O'Reilly EM
Cancer; 2012 Jun; 118(12):3053-61. PubMed ID: 21989534
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer and thromboembolism in the ambulatory community.
Kornreich DA; Saif MW
JOP; 2012 Mar; 13(2):185-6. PubMed ID: 22406598
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolisms in Advanced Pancreatic Cancer: A Retrospective Analysis of 475 Patients.
Ishigaki K; Nakai Y; Isayama H; Saito K; Hamada T; Takahara N; Mizuno S; Mohri D; Kogure H; Matsubara S; Yamamoto N; Tada M; Koike K
Pancreas; 2017 Sep; 46(8):1069-1075. PubMed ID: 28787333
[TBL] [Abstract][Full Text] [Related]
4. Impact of Body Mass Index on Survival of Pancreatic Cancer Patients in Japan.
Okura T; Fujii M; Shiode J; Ito Y; Kojima T; Nasu J; Niguma T; Yoshioka M; Mimura T; Yamamoto K
Acta Med Okayama; 2018 Apr; 72(2):129-135. PubMed ID: 29674761
[TBL] [Abstract][Full Text] [Related]
5. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Li D; Pise MN; Overman MJ; Liu C; Tang H; Vadhan-Raj S; Abbruzzese JL
Cancer Med; 2015 Nov; 4(11):1651-8. PubMed ID: 26275671
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
Starling N; Rao S; Cunningham D; Iveson T; Nicolson M; Coxon F; Middleton G; Daniel F; Oates J; Norman AR
J Clin Oncol; 2009 Aug; 27(23):3786-93. PubMed ID: 19398575
[TBL] [Abstract][Full Text] [Related]
7. Risks and impacts of thromboembolism in patients with pancreatic cancer.
Chan LL; Lam KY; Lam DCM; Lau YM; Li L; Ng KKC; Tang RSY; Chan SL
Hong Kong Med J; 2023 Oct; 29(5):396-403. PubMed ID: 37789507
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
9. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
[TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.
Pedde D; Soltani S; Stein J; Tsyganenko D; Müller M; Schönrath F; Falk V; Potapov EV
Eur J Cardiothorac Surg; 2020 Feb; 57(2):325-330. PubMed ID: 31317177
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study.
Kumar S; Chapagain A; Nitsch D; Yaqoob MM
BMC Nephrol; 2012 Sep; 13():107. PubMed ID: 22963194
[TBL] [Abstract][Full Text] [Related]
12. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
[TBL] [Abstract][Full Text] [Related]
13. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study.
Pelland-Marcotte MC; Pole JD; Kulkarni K; Athale U; Stammers D; Sabapathy C; Halparin J; Brandão LR; Sung L
Thromb Haemost; 2018 Sep; 118(9):1646-1655. PubMed ID: 30103249
[TBL] [Abstract][Full Text] [Related]
15. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolism and anticoagulation in pancreatic cancer.
Habib M; Saif MW
JOP; 2013 Mar; 14(2):135-7. PubMed ID: 23474555
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1354-64. PubMed ID: 12867585
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolism preceding cancer: a correlation study.
Saba HI; Khalil FK; Morelli GA; Foulis PR
Am J Hematol; 2003 Feb; 72(2):109-14. PubMed ID: 12555214
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study.
Lee JC; Ro YS; Cho J; Park Y; Lee JH; Hwang JH; Choi HJ; Lee S
Medicine (Baltimore); 2016 Apr; 95(17):e3472. PubMed ID: 27124043
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
Layton D; Heeley E; Hughes K; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1342-53. PubMed ID: 12832706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
